Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
METTL17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PLEKHG4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO44 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MUC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
KRT77 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZMAT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XAGE-4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM139 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01111 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
P2RX6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAMK2N1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAMTS6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCL11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRDM10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EDN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DOCK4-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on